NCT02274272View on ClinicalTrials.gov

Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

May 31, 2017

Conditions
Type 2 Diabetes
Interventions
OTHER

ADR-1

two ADR-1 capsules, once daily, QD

OTHER

GMNL-263

two GMNL-263 capsules, once daily, QD

OTHER

placebo

two placebo capsules, once daily, QD

Trial Locations (1)

Unknown

Genmont, Tainan City

All Listed Sponsors
lead

GenMont Biotech Incorporation

INDUSTRY

NCT02274272 - Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter